• Issue

    Histopathology: Volume 86, Issue 4

    483-659
    March 2025

Issue Information

Free Access

Issue Information

  • Pages: 483-484
  • First Published: 04 February 2025

Review

Open Access

Tumour deposits are associated with worse survival than extranodal extension; a network meta-analysis on tumour nodules in colorectal cancer

  • Pages: 485-496
  • First Published: 28 August 2024
Tumour deposits are associated with worse survival than extranodal extension; a network meta-analysis on tumour nodules in colorectal cancer

This systematic review compares LNM+, LNM + TD+ and LNM + ENE+ cases using network meta-analyses. As LNM+TD+ has a worse outcome than LNM +E NE+ and both groups perform worse than cases with LNM only, more emphasis on both ENE and TD in the TNM classification is needed, with the most prominent role for TD.

Open Access

Controversies regarding encapsulated papillary carcinoma of the breast: an approach to evaluation and categorisation

  • Pages: 497-513
  • First Published: 29 August 2024
Controversies regarding encapsulated papillary carcinoma of the breast: an approach to evaluation and categorisation

This review summarizes the common diagnostic pitfalls in malignant papillary tumours of the breast, with particular focus on encapsulated papillary carcinoma, and provide an approach to the diagnostic evaluation and categorisation of these enigmatic entities.

Original Article

Evolution of morphological changes in donor livers undergoing normothermic machine perfusion

  • Pages: 516-524
  • First Published: 20 November 2024
Evolution of morphological changes in donor livers undergoing normothermic machine perfusion

The histological changes in liver biopsies taken during the normothermic machine perfusion (NMP) pathway predominantly comprise donor-derived macrovesicular steatosis, stress-associated small droplet steatosis, retrieval/procedure-associated sinusoidal dilation and ischaemic injury. Regional variations in necrosis extent are likely to limit the utility of biopsies taken during NMP to assess organ quality.

Open Access

Clinicopathologic features and outcomes of hepatic inflammatory pseudotumour (IPT) and hepatic IPT-like lesions

  • Pages: 525-535
  • First Published: 31 October 2024
Clinicopathologic features and outcomes of hepatic inflammatory pseudotumour (IPT) and hepatic IPT-like lesions

In this retrospective study of 80 patients with biopsy-proven hepatic inflammatory pseudotumour (IPT), patients commonly have a history of biliary disease (15%) or prior intraabdominal surgery (24%). Most patients with available clinical follow-up demonstrated radiologic resolution and/or had repeat negative biopsy; a minority of patients (8%) were subsequently diagnosed with neoplastic hepatic lesions.

Open Access

Evaluation of breast-specific marker expression in metastatic breast cancers: Correlation with subtype switch

  • Pages: 536-546
  • First Published: 31 October 2024
Evaluation of breast-specific marker expression in metastatic breast cancers: Correlation with subtype switch

GATA3 retains high sensitivity in HR+ cancers, even after HR loss during metastasis. TRPS1 and SOX10 were expressed in more than 50% of concordant TNBC cases, indicating their utility in identifying TNBC metastasis.

Correlation between CTNNB1 mutation status and tumour phenotype in hepatitis B virus-related hepatocellular carcinoma

  • Pages: 547-558
  • First Published: 11 November 2024
Correlation between CTNNB1 mutation status and tumour phenotype in hepatitis B virus-related hepatocellular carcinoma

CTNNB1 mutations were found in 13% of cases, exclusively in exon 3, with mutations at D32-S37, T41 and S45. CTNNB1 mutations correlated strongly with diffuse strong glutamine synthetase (GS) expression, nuclear β-catenin expression and classic CTNNB1 morphology.

Open Access

Neuroendocrine differentiation and serotonin expression in oesophageal adenocarcinomas after neoadjuvant therapy: correlation with clinicopathological features and outcome

  • Pages: 559-570
  • First Published: 11 November 2024
Neuroendocrine differentiation and serotonin expression in oesophageal adenocarcinomas after neoadjuvant therapy: correlation with clinicopathological features and outcome

Expression of neuroendocrine markers in oesophageal adenocarcinoma after neoadjuvant chemoradiation is independently associated with reduced overall survival. Assessment of neuroendocrine differentiation is a useful tool for predicting patient outcome.

Open Access

Sinonasal adenosquamous carcinomas arising in seromucinous hamartoma or respiratory epithelial adenomatoid hamartoma with atypical features: Report of five detailed clinicopathological and molecular characterisation of rare entity

  • Pages: 585-602
  • First Published: 20 November 2024
Sinonasal adenosquamous carcinomas arising in seromucinous hamartoma or respiratory epithelial adenomatoid hamartoma with atypical features: Report of five detailed clinicopathological and molecular characterisation of rare entity

The tumour was covered by respiratory mucosa without metaplastic or dysplastic changes with branched glands of REAH descending from the surface respiratory epithelium into the stroma with budding structures of SH and ASGSH glands (A). Detailed SH transforming into ASGSH (B). AMP staining showing ASGSH with reduced brush border and mucin production (C). REAH glands were branched and consisted of multiple layers of secretory and myoepithelial cells with irregular and disorganized stratification and chaotic arrangement of nuclei (D).

Open Access

Diagnostic features in paediatric MDS-EB with UBTF-internal tandem duplication: defining a unique subgroup

  • Pages: 603-610
  • First Published: 20 November 2024
Diagnostic features in paediatric MDS-EB with UBTF-internal tandem duplication: defining a unique subgroup

Distinctive histopathological features of paediatric MDS with UBTF-TD include hyperplastic myelopoiesis with severe atypia, frequent micromegakaryocytes, and immature erythropoiesis with circulating normoblasts. These findings may aid in the early diagnosis and guide targeted molecular testing and treatment strategies, which are critical to improving patient outcomes.

Initiation of molecular testing of endometrial carcinomas in a population-based setting: practical considerations and pitfalls

  • Pages: 611-626
  • First Published: 28 November 2024
Initiation of molecular testing of endometrial carcinomas in a population-based setting: practical considerations and pitfalls

This represents the first population-based study investigating the prevalence of the different TCGA molecular groups of endometrial carcinomas in an unselected population. Performing molecular testing on biopsies enables management to be tailored to the molecular group and allows integration of the TCGA group into the report of the final resection specimen.

Open Access

Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillance

  • Pages: 627-639
  • First Published: 28 November 2024
Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillance

Cancer infiltrates in prostate biopsies are reported in various ways, commonly in percentages or mm, which was confirmed in a survey of genitourinary pathologists. Further, 10 typical cases mirrored this variability in practice. A greater variability was seen for percentages in reporting prostate cancer extent. Therefore, absolute measures (mm) are preferable.